check stock prices

The narrative about U.S. economic growth and financial markets has changed since Donald Trump won the presidential election.

Gone are the days when we talk about central banks, monetary stimulus and low rates. We are in a brave new world of bold fiscal spending plans, tax reforms, rising inflation and rising interest rates.

Whether you are a supporter of the president-elect or not, understanding the implications of the new administration on the economy can be daunting. So weve compiled a list of few prominent economists whose blogs can give you valuable insight.

check stock prices: Old Point Financial Corporation(OPOF)

Advisors’ Opinion:

  • [By Lisa Levin]

    In trading on Wednesday, financial shares fell 0.13 percent. Meanwhile, top losers in the sector included Adams Natural Resources Fund Inc (NYSE: PEO), down 4 percent, and Old Point Financial Corporation (NASDAQ: OPOF) down 3 percent.

check stock prices: Curis, Inc.(CRIS)

Advisors’ Opinion:

  • [By Paul Ausick]

    Curis Inc. (NASDAQ: CRIS) matched a 52-week low of $0.88 set Friday. The 52-week high is $3.48. Volume was about 4 million, four times the daily average of around 1 million. The drugmaker had no specific news Monday.

  • [By Ben Levisohn]

    Skorney’s namesVertex Pharmaceuticals (VRTX),Sarepta Therapeutics (SRPT), and Curis (CRIS) his top biotech picks for 2017, while Ulz chosesBioMarin Pharmaceutical (BMRN) andParatek Pharmaceuticals (PRTK).

  • [By Alex McGuire]

    These are the 10 best penny stocks that have seen the biggest returns over the last week (March 7 – March 14)…

    Penny StockCurrent PriceWeekly Gain (March 7 – March 14)Ocera Therapeutics Inc. (Nasdaq: OCRX)$1.47+147.1%Internap Corp. (Nasdaq: INAP)$3.28+41.4%Soligenix Inc. (Nasdaq: SNGX)$2.94+40%Navios Maritime Partners LP (NYSE: NMM)$2.63+37%QuickLogic Corp. (Nasdaq: QUIK)$2.14+30.5%Adamis Pharmaceuticals Corp. (Nasdaq: ADMP)$4.60+22.7EXCO Resources Inc. (NYSE: XCO)$0.65+20.5%Cyclacel Pharmaceuticals Inc. (Nasdaq: CYCC)$4.38+20.3%Hebron Technology Co. Ltd. (Nasdaq: HEBT)$3.99+19.1%Curis Inc. (Nasdaq: CRIS)$2.85+18.4%

    As a reminder, this is only a tracking metric of penny stocks trading on SEC-regulated exchanges like the Nasdaq and NYSE. Although these top penny stocks are safer than those trading on the pink sheets, we don’t recommend buying any of them without the proper amount of financial research.

check stock prices: U.S. Silica Holdings, Inc.(SLCA)

Advisors’ Opinion:

  • [By Tyler Crowe, Tim Brugger, and Jordan Wathen]

    With that in mind, we asked three of our contributors to highlight a company they will be following closely in the first quarter and why. Here’s what makes Adobe Systems (NASDAQ:ADBE), Charles Schwab (NYSE:SCHW), and U.S. Silica Holdings (NYSE:SLCA) worth following when the next earnings report comes out.

  • [By Peter Graham]

    The Q4 2016 earnings report formid cap proppant and fracking stock U.S. Silica Holdings Inc (NYSE: SLCA)is scheduled for after the market closes onWednesday (February 22nd). Proppant and fracking stockswere crushed by low oil prices; but with oil prices stabilizing, drilling activity coming back to the oil patches.

  • [By Peter Graham]

    A long term performance chart shows shares of CARBO Ceramics performing much worst thanfracking peers U.S. Silica Holdings Inc (NYSE: SLCA) and Hi-Crush Partners LP (NYSE: HCLP) which showed signs of recovery in 2016, but that recoveryhas since fallen off:

check stock prices: (SMPQY)

Advisors’ Opinion:

  • [By SEEKINGALPHA.COM]

    We believe that two main risks currently exist. First, a few days ago, U.S. Department of Justice filed charges in generic drug price-fixing probe. The U.S. Department of Justice accused two former generic pharmaceutical executives of colluding with other generic manufacturers to fix prices – the first criminal charges stemming from a two-year investigation. Companies in the congressional probe have since publicly disclosed that they have received subpoenas, including Mylan NV (NASDAQ:MYL), Allergan (NYSE:AGN), which later sold its generics business to Teva (NASDAQ:TEVA), Lannett (NYSEMKT:LCI), Impax Laboratories (NASDAQ:IPXL), Endo International (NASDAQ

Leave a Reply

Your email address will not be published. Required fields are marked *